As we know, the most widely identified variant for human NAFLD is located in one lipid droplet remodelling-related genes, PNPLA3 and this mutation increased fat contents in hepatocytes. Here, PNPLA3 is linked to metabolic dysfunction-associated steatotic liver disease.